These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mineralocorticoid activity of 16beta-hydroxydehydroepiandrosterone and related steroids. Gomez-Sanchez C; Holland OB; Higgins JR; Mathieu R; Gruber GM; Milewich L; Kaplan NM J Lab Clin Med; 1976 Oct; 88(4):571-7. PubMed ID: 135037 [TBL] [Abstract][Full Text] [Related]
3. 16Beta-hydroxydehydroepiandrosterone: the dichotomy between renal receptor binding and urinary electrolyte activity. Funder JW; Robinson JA; Feldman D; Wynne KN; Adam WR Endocrinology; 1976 Aug; 99(2):619-28. PubMed ID: 182463 [TBL] [Abstract][Full Text] [Related]
4. Evidence for a new mineralocorticoid in patients with low-renin essential hypertension. Sennett JA; Brown RD; Island DP; Yarbro LR; Watson JT; Slaton PE; Hollifield JW; Liddle GW Circ Res; 1975 Jun; 36(6 Suppl 1):2-9. PubMed ID: 124232 [TBL] [Abstract][Full Text] [Related]
5. Mineralocorticoid receptors in human kidney. Matulich DT; Spindler BJ; Schambelan M; Baxter JD J Clin Endocrinol Metab; 1976 Nov; 43(5):1170-4. PubMed ID: 993320 [TBL] [Abstract][Full Text] [Related]
6. Aldosterone receptors and the evaluation of plasma mineralocorticoid activity in normal and hypertensive states. Baxter JD; Schambelan M; Matulich DT; Spindler BJ; Taylor AA; Bartter FC J Clin Invest; 1976 Sep; 58(3):579-89. PubMed ID: 182723 [TBL] [Abstract][Full Text] [Related]
7. Radioreceptor assay of plasma mineralocorticoid activity. Role of aldosterone, cortisol, and deoxycorticosterone in various mineralocorticoid-excess states. Lan NC; Matulich DT; Stockigt JR; Biglieri EG; New MI; Winter JS; McKenzie JK; Baxter JD Circ Res; 1980 Jun; 46(6 Pt 2):I94-100. PubMed ID: 6991154 [No Abstract] [Full Text] [Related]
8. Mineralocorticoid and renal receptor binding activity of 21-deoxyaldosterone. Koshida H; Miyamori I; Soma R; Matsubara T; Ikeda M; Takeda R; Nakamura S; Kiuchi F; Tsuda Y Endocrinology; 1990 Mar; 126(3):1410-5. PubMed ID: 2155101 [TBL] [Abstract][Full Text] [Related]
9. Affinity of 18,19-dihydroxydeoxycorticosterone and 18-hydroxy-19-nor-deoxycorticosterone to aldosterone receptor and their mineralocorticoid activity. Okamoto M; Momoi K; Yamano T; Nakamura M; Odaguchi K; Shimizu T; Okada T; Terasawa T Biochem Int; 1983 Dec; 7(6):687-94. PubMed ID: 6237653 [TBL] [Abstract][Full Text] [Related]
10. Renal receptor-binding activity of reduced metabolites of aldosterone: evidence for a mineralocorticoid effect outside of the classic aldosterone receptor system. Gomez-Sanchez CE; Smith JS; Ferris MW; Gomez-Sanchez EP Endocrinology; 1984 Aug; 115(2):712-5. PubMed ID: 6086276 [TBL] [Abstract][Full Text] [Related]
11. Intrinsic mineralocorticoid agonist activity of some nonsteroidal anti-inflammatory drugs. A postulated mechanism for sodium retention. Feldman D; Couropmitree C J Clin Invest; 1976 Jan; 57(1):1-7. PubMed ID: 173739 [TBL] [Abstract][Full Text] [Related]
13. Relationships of the molecular structure of aldosterone derivatives with their binding affinity for mineralocorticoid receptor. Yamakawa M; Ezumi K; Shiro M; Nakai H; Kamata S; Matsui T; Haga N Mol Pharmacol; 1986 Dec; 30(6):585-9. PubMed ID: 3023811 [TBL] [Abstract][Full Text] [Related]
14. Mineralocorticoid like effect of new 18-hydroxy-steroid isolated from urine of hypertensive patients. Palem-Vliers M; Fontaine F; Genard P Endocrinol Exp; 1976 Mar; 10(1):59-63. PubMed ID: 1083802 [TBL] [Abstract][Full Text] [Related]
15. Role of steroids in hypertension: evaluation of plasma mineralocorticoid activity with aldosterone receptors. Baxter JD; Schambelan M; Matulich DT; Spindler BJ; Bartter FC Clin Sci Mol Med Suppl; 1976 Dec; 3():321s-324s. PubMed ID: 1071637 [TBL] [Abstract][Full Text] [Related]
16. Effect of aminoglutethimide on blood pressure and steroid secretion in patients with low renin essential hypertension. Taylor AA; Mitchell JR; Bartter FC; Snodgrass WR; McMurtry RJ; Gill JR; Franklin RB J Clin Invest; 1978 Jul; 62(1):162-8. PubMed ID: 149141 [TBL] [Abstract][Full Text] [Related]
17. New mineralocorticoids and adrenocorticosteroids in hypertension. Melby JC; Dale SL Am J Cardiol; 1976 Nov; 38(6):805-13. PubMed ID: 136892 [TBL] [Abstract][Full Text] [Related]
18. Vascular type I aldosterone binding sites are physiological mineralocorticoid receptors. Funder JW; Pearce PT; Smith R; Campbell J Endocrinology; 1989 Oct; 125(4):2224-6. PubMed ID: 2551643 [TBL] [Abstract][Full Text] [Related]
19. Studies on arterial mineralocorticoid and glucocorticoid receptors: evidence for the translocation of steroid-cytoplasmic receptor complexes to cell nuclei. Kornel L; Kanamarlapudi N; Ramsay C; Taff DJ Clin Physiol Biochem; 1984; 2(1):14-31. PubMed ID: 6091978 [TBL] [Abstract][Full Text] [Related]
20. The conversion of 16β hydroxyldehydroepiandrosterone in human serum. Ke Y; Gonthier R; Labrie F Steroids; 2016 May; 109():50-5. PubMed ID: 26896786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]